ASX - By Stock
|
PAR Biotech |
Re:
Lorecivivint
|
|
Leroy65
|
26 |
13K |
3 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
26
|
13K
|
3
|
|
ASX - By Stock
|
PAR Biotech |
Re:
Lorecivivint
|
|
Leroy65
|
26 |
13K |
5 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
26
|
13K
|
5
|
|
ASX - By Stock
|
PAR Biotech |
Re:
Lorecivivint
|
|
Leroy65
|
26 |
13K |
0 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
26
|
13K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Leroy65
|
4.2K |
3.8M |
4 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
3 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
2 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
2 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
Leroy65
|
191 |
75K |
54 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
191
|
75K
|
54
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Leroy65
|
150 |
74K |
4 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
150
|
74K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Leroy65
|
150 |
74K |
7 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
150
|
74K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Leroy65
|
150 |
74K |
9 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
150
|
74K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Date of Annual General Meeting
|
|
Leroy65
|
14 |
5.1K |
6 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
14
|
5.1K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Date of Annual General Meeting
|
|
Leroy65
|
14 |
5.1K |
5 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
14
|
5.1K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
|
|
Leroy65
|
294 |
116K |
18 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
294
|
116K
|
18
|
|
ASX - By Stock
|
PAR |
Re:
Community Adoption / Mr Federer
|
|
Leroy65
|
116 |
37K |
3 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
116
|
37K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Community Adoption / Mr Federer
|
|
Leroy65
|
116 |
37K |
19 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
116
|
37K
|
19
|
|
ASX - By Stock
|
PAR |
Re:
iPPS and the not so Looney comparison
|
|
Leroy65
|
48 |
15K |
3 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
48
|
15K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Leroy65
|
4.2K |
3.8M |
5 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
3 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
10 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Conference Call 3/8/21
|
|
Leroy65
|
65 |
22K |
2 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
65
|
22K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Conference Call 3/8/21
|
|
Leroy65
|
65 |
22K |
3 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
65
|
22K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Leroy65
|
318 |
136K |
8 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
318
|
136K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Where are PAR shareholders located?
|
|
Leroy65
|
115 |
28K |
2 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
115
|
28K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Leroy65
|
4.2K |
3.8M |
1 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Leroy65
|
4.2K |
3.8M |
7 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Leroy65
|
4.2K |
3.8M |
2 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Leroy65
|
4.2K |
3.8M |
9 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: NOTICE OF RELEASE OF ESCROWED SECURITIES
|
|
Leroy65
|
6 |
3.5K |
3 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
6
|
3.5K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: IND QUESTIONS RECEIVED FROM US FDA
|
|
Leroy65
|
389 |
123K |
2 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
389
|
123K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: IND QUESTIONS RECEIVED FROM US FDA
|
|
Leroy65
|
389 |
123K |
0 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
389
|
123K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: IND QUESTIONS RECEIVED FROM US FDA
|
|
Leroy65
|
389 |
123K |
0 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
389
|
123K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
3 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: IND QUESTIONS RECEIVED FROM US FDA
|
|
Leroy65
|
389 |
123K |
5 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
389
|
123K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
3 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
3 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
3 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
1 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
1 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Leroy65
|
4.2K |
3.8M |
6 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
8 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
8
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
0 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm to Present at Truist Securities Life Sciences Summi
|
|
Leroy65
|
19 |
8.8K |
0 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
19
|
8.8K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm to Present at Truist Securities Life Sciences Summi
|
|
Leroy65
|
19 |
8.8K |
1 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
19
|
8.8K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
2 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.1K |
1.9M |
1 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM PROVIDES IND APPLICATION UPDATE
|
|
Leroy65
|
103 |
44K |
4 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
103
|
44K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Delay = Buy Opportunity
|
|
Leroy65
|
22 |
8.9K |
9 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
22
|
8.9K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM PROVIDES IND APPLICATION UPDATE
|
|
Leroy65
|
103 |
44K |
2 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
103
|
44K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
We just submitted an IND - So now what?
|
|
Leroy65
|
133 |
37K |
1 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
133
|
37K
|
1
|
|